{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:22:45Z","timestamp":1793744565644,"version":"4.6.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004238","name":"Universit\u00e4t Potsdam","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004238","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The transition from metabolic dysfunction-associated steatotic liver disease (MASLD) to steatohepatitis (MASH) is characterized by a chronic low-grade inflammation, involving activation of resident macrophages (Kupffer cells; KC) and recruitment of infiltrating macrophages. Macrophages produce cytokines and, after induction of Cyclooxygenase 2 (COX-2), the key enzyme of prostanoid synthesis, prostaglandin E\n                      <jats:sub>2<\/jats:sub>\n                      (PGE\n                      <jats:sub>2<\/jats:sub>\n                      ). PGE\n                      <jats:sub>2<\/jats:sub>\n                      modulates cytokine production in an autocrine and paracrine manner, therefore playing a pivotal role in regulating inflammatory processes. Changes in the hepatic macrophage pool during MASLD progression to MASH could influence PGE\n                      <jats:sub>2<\/jats:sub>\n                      - and cytokine-mediated signaling processes. The aim of this study was to characterize these changes in mice with diet-induced MASH and further elucidate the role of COX-2-dependently formed PGE\n                      <jats:sub>2<\/jats:sub>\n                      on the inflammatory response in different macrophage populations of mice with a macrophage-specific COX-2-deletion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Male, 6-7-week-old wildtype mice were fed either a Standard or high-fat, high-cholesterol MASH-inducing diet for 4, 12 and 20 weeks. Liver macrophages were isolated and analyzed by flow cytometry. For in vitro experiments primary KC, peritoneal macrophages (PM) and Bone-marrow-derived macrophages (BMDM) were isolated from macrophage-specific COX-2-deficient and wildtype mice and treated with lipopolysaccharide (LPS) and\/or PGE\n                      <jats:sub>2<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During MASH-development, the proportion of KC (Clec4F\n                      <jats:sup>+<\/jats:sup>\n                      Tim4\n                      <jats:sup>+<\/jats:sup>\n                      ) decreased, while the proportion of monocyte-derived macrophages (Clec4F\n                      <jats:sup>\u2212<\/jats:sup>\n                      Tim4\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) and monocyte-derived cells exhibiting a phenotype similar to KC (Clec4F\n                      <jats:sup>+<\/jats:sup>\n                      Tim4\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) significantly increased over time. In vitro experiments showed that exogenous PGE\n                      <jats:sub>2<\/jats:sub>\n                      completely abrogated the LPS-induced mRNA expression and secretion of tumor necrosis factor-alpha (TNF-\u03b1) in primary KC, PM and BMDM from wildtype mice. PM and BMDM, as in vitro models for infiltrating macrophages, were more sensitive to PGE\n                      <jats:sub>2<\/jats:sub>\n                      compared to KC. Deletion of COX-2 in all macrophage populations led to an impaired PGE\n                      <jats:sub>2<\/jats:sub>\n                      -dependent feedback inhibition of TNF-\u03b1 production. LPSinduced TNF-\u03b1 mRNA expression was higher compared to the respective wildtype macrophage population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The current study, using a murine MASH model, indicates that PGE\n                      <jats:sub>2<\/jats:sub>\n                      may have a protective, anti-inflammatory effect, especially by inhibiting the expression of pro-inflammatory cytokines such as TNF\u03b1 in infiltrating monocyte-derived macrophages. An inhibition of endogenous PGE\n                      <jats:sub>2<\/jats:sub>\n                      synthesis in macrophages by pharmacological inhibition of COX-2 could potentially increase inflammation and promote the progression of MASH.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-025-02222-y","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:37:55Z","timestamp":1747377475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dynamic changes in macrophage populations and resulting alterations in Prostaglandin E2 sensitivity in mice with diet-induced MASH"],"prefix":"10.1186","volume":"23","author":[{"given":"Madita","family":"Vahrenbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Lurje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hammerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Keye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Schjeide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hi\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. P.","family":"P\u00fcschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Henkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"6","key":"2222_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386. https:\/\/doi.org\/10.1097\/HEP.0000000000000520.","journal-title":"Hepatology"},{"issue":"1","key":"2222_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"9","key":"2222_CR3","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023;119(9):1787\u201398. https:\/\/doi.org\/10.1093\/cvr\/cvad095.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2222_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2010","unstructured":"Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. Int J Med. 2010;103(2):71\u201383. https:\/\/doi.org\/10.1093\/qjmed\/hcp158.","journal-title":"Int J Med"},{"issue":"1","key":"2222_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology"},{"issue":"6","key":"2222_CR6","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity","year":"2016","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u2013402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004.","journal-title":"J Hepatol"},{"issue":"7","key":"2222_CR7","doi-asserted-by":"publisher","first-page":"e0159524","DOI":"10.1371\/journal.pone.0159524","volume":"11","author":"DT Reid","year":"2016","unstructured":"Reid DT, Reyes JL, McDonald BA, Vo T, Reimer RA, Eksteen B. Kupffer cells undergo fundamental changes during the development of experimental NASH and are critical in initiating liver damage and inflammation. PLoS ONE. 2016;11(7):e0159524. https:\/\/doi.org\/10.1371\/journal.pone.0159524.","journal-title":"PLoS ONE"},{"issue":"4","key":"2222_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1053\/he.2000.5634","volume":"31","author":"GL Su","year":"2000","unstructured":"Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, et al. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology. 2000;31(4):932\u20136. https:\/\/doi.org\/10.1053\/he.2000.5634.","journal-title":"Hepatology"},{"key":"2222_CR9","doi-asserted-by":"publisher","first-page":"193doi","DOI":"10.1186\/s12967-015-0552-7","volume":"13","author":"M Ganz","year":"2015","unstructured":"Ganz M, Bukong TN, Csak T, Saha B, Park J-K, Ambade A, et al. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. J Transl Med. 2015;13:193doi. https:\/\/doi.org\/10.1186\/s12967-015-0552-7.","journal-title":"J Transl Med"},{"issue":"1","key":"2222_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-0043-118666","volume":"50","author":"S Kakino","year":"2018","unstructured":"Kakino S, Ohki T, Nakayama H, Yuan X, Otabe S, Hashinaga T, et al. Pivotal role of TNF-\u03b1 in the development and progression of nonalcoholic fatty liver disease in a murine model. Horm Metab Res. 2018;50(1):80\u20137. https:\/\/doi.org\/10.1055\/s-0043-118666.","journal-title":"Horm Metab Res"},{"issue":"1","key":"2222_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","volume":"47","author":"IA Leclercq","year":"2007","unstructured":"Leclercq IA, Da Silva Morais A, Schroyen B, van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol. 2007;47(1):142\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2007.04.002.","journal-title":"J Hepatol"},{"issue":"3","key":"2222_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1476-5381.2012.02182.x","volume":"168","author":"F Neusch\u00e4fer-Rube","year":"2013","unstructured":"Neusch\u00e4fer-Rube F, Pathe-Neusch\u00e4fer-Rube A, Hippenstiel S, Kracht M, P\u00fcschel GP. NF-\u03baB-dependent IL-8 induction by prostaglandin E(2) receptors EP(1) and EP(4). Br J Pharmacol. 2013;168(3):704\u201317. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02182.x.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"2222_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/labinvest.2011.47","volume":"91","author":"J Henkel","year":"2011","unstructured":"Henkel J, G\u00e4rtner D, Dorn C, Hellerbrand C, Schanze N, Elz SR, P\u00fcschel GP. Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis. Lab Invest. 2011;91(7):1107\u201317. https:\/\/doi.org\/10.1038\/labinvest.2011.47.","journal-title":"Lab Invest"},{"key":"2222_CR14","doi-asserted-by":"publisher","unstructured":"Henkel J, Klauder J, Statz M, Wohlenberg A-S, Kuipers S, Vahrenbrink M, P\u00fcschel GP. Enhanced Palmitate-Induced Interleukin-8 formation in human macrophages by insulin or prostaglandin E2. Biomedicines. 2021;9(5). https:\/\/doi.org\/10.3390\/biomedicines9050449.","DOI":"10.3390\/biomedicines9050449"},{"issue":"46","key":"2222_CR15","doi-asserted-by":"publisher","first-page":"44147","DOI":"10.1074\/jbc.M204810200","volume":"277","author":"K Takayama","year":"2002","unstructured":"Takayama K, Garc\u00eda-Cardena G, Sukhova GK, Comander J, Gimbrone MA, Libby P. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem. 2002;277(46):44147\u201354. https:\/\/doi.org\/10.1074\/jbc.M204810200.","journal-title":"J Biol Chem"},{"issue":"3","key":"2222_CR16","first-page":"446","volume":"84","author":"WW Zhong","year":"1995","unstructured":"Zhong WW, Burke PA, Drotar ME, Chavali SR, Forse RA. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunol. 1995;84(3):446\u201352.","journal-title":"Immunol"},{"issue":"4","key":"2222_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00000658-199404000-00010","volume":"219","author":"CR Roland","year":"1994","unstructured":"Roland CR, Goss JA, Mangino MJ, Hafenrichter D, Flye M. Autoregulation by eicosanoids of human Kupffer cell secretory products. A study of interleukin-1, interleukin-6, tumor necrosis factor-alpha, transforming growth factor-beta, and nitric oxide. Ann Surg Surg. 1994;219(4):389\u201399. https:\/\/doi.org\/10.1097\/00000658-199404000-00010.","journal-title":"Ann Surg Surg"},{"issue":"1","key":"2222_CR18","doi-asserted-by":"publisher","first-page":"16127","DOI":"10.1038\/s41598-018-34633-y","volume":"8","author":"J Henkel","year":"2018","unstructured":"Henkel J, Coleman CD, Schraplau A, J\u00f6hrens K, Weiss TS, Jonas W, et al. Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model. Sci Rep. 2018;8(1):16127. https:\/\/doi.org\/10.1038\/s41598-018-34633-y.","journal-title":"Sci Rep"},{"issue":"9","key":"2222_CR19","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.bbadis.2016.06.009","volume":"1862","author":"O Moti\u00f1o","year":"2016","unstructured":"Moti\u00f1o O, Agra N, Brea Contreras R, Dom\u00ednguez-Moreno M, Garc\u00eda-Monz\u00f3n C, Vargas-Castrill\u00f3n J, et al. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice. BBA. 2016;1862(9):1710\u201323. https:\/\/doi.org\/10.1016\/j.bbadis.2016.06.009.","journal-title":"BBA"},{"key":"2222_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cellimm.2017.10.006","volume":"322","author":"L Devisscher","year":"2017","unstructured":"Devisscher L, Scott CL, Lefere S, Raevens S, Bogaerts E, Paridaens A, et al. Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool. Cell Immunol. 2017;322:74\u201383. https:\/\/doi.org\/10.1016\/j.cellimm.2017.10.006.","journal-title":"Cell Immunol"},{"key":"2222_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2119\/molmed.2016.00203","volume":"23","author":"J Henkel","year":"2017","unstructured":"Henkel J, Coleman CD, Schraplau A, J\u04e7hrens K, Weber D, Castro JP, et al. Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol. Mol Med. 2017;23:70\u201382. https:\/\/doi.org\/10.2119\/molmed.2016.00203.","journal-title":"Mol Med"},{"key":"2222_CR22","doi-asserted-by":"publisher","unstructured":"Henkel J, Alfine E, Sa\u00edn J, J\u00f6hrens K, Weber D, Castro JP, et al. Soybean Oil-Derived Poly-Unsaturated fatty acids enhance liver damage in NAFLD induced by dietary cholesterol. Nutrients. 2018;10(9). https:\/\/doi.org\/10.3390\/nu10091326.","DOI":"10.3390\/nu10091326"},{"issue":"4","key":"2222_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/a:1008942828960","volume":"8","author":"BE Clausen","year":"1999","unstructured":"Clausen BE, Burkhardt C, Reith W, Renkawitz R, F\u00f6rster I. Conditional gene targeting in macrophages and granulocytes using lysmcre mice. Transgenic Res. 1999;8(4):265\u201377. https:\/\/doi.org\/10.1023\/a:1008942828960.","journal-title":"Transgenic Res"},{"issue":"3","key":"2222_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/carcin\/bgq268","volume":"32","author":"T-O Ishikawa","year":"2011","unstructured":"Ishikawa T-O, Oshima M, Herschman HR. Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis. Carcinog. 2011;32(3):417\u201326. https:\/\/doi.org\/10.1093\/carcin\/bgq268.","journal-title":"Carcinog"},{"key":"2222_CR25","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"7","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol. 2010;7:1573\u20136.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2222_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/s0168-8278(01)00277-x","volume":"36","author":"A Fennekohl","year":"2002","unstructured":"Fennekohl A, Sugimoto Y, Segi E, Maruyama T, Ichikawa A, P\u00fcschel GP. Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the Inhibition by PGE2 of the LPS-induced TNF\u03b1-formation in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells. J Hepatol. 2002;36(3):328\u201334. https:\/\/doi.org\/10.1016\/s0168-8278(01)00277-x.","journal-title":"J Hepatol"},{"key":"2222_CR27","doi-asserted-by":"crossref","unstructured":"Ray A, Dittel BN. Isolation of mouse peritoneal cavity cells. JoVE; 2010.","DOI":"10.3791\/1488"},{"key":"2222_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-4939-2929-0_6","volume":"1339","author":"I Pineda-Torra","year":"2015","unstructured":"Pineda-Torra I, Gage M, de Juan A, Pello OM. Isolation, culture, and polarization of murine bone Marrow-Derived and peritoneal macrophages. Methods Mol Biol. 2015;1339:101\u20139. https:\/\/doi.org\/10.1007\/978-1-4939-2929-0_6.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2222_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/hep.23064","volume":"50","author":"J Henkel","year":"2009","unstructured":"Henkel J, Neusch\u00e4fer-Rube F, Pathe-Neusch\u00e4fer-Rube A, P\u00fcschel GP. Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes. Hepatology. 2009;50(3):781\u201390. https:\/\/doi.org\/10.1002\/hep.23064.","journal-title":"Hepatology"},{"issue":"4","key":"2222_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","volume":"51","author":"J Bonnardel","year":"2019","unstructured":"Bonnardel J, T\u2019Jonck W, Gaublomme D, Browaeys R, Scott CL, Martens L, et al. Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche. Immunity. 2019;51(4):638\u2013e6549. https:\/\/doi.org\/10.1016\/j.immuni.2019.08.017.","journal-title":"Immunity"},{"issue":"16","key":"2222_CR31","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"2007","unstructured":"Sugimoto Y, Narumiya S. Prostaglandin E receptors. JBC. 2007;282(16):11613\u20137. https:\/\/doi.org\/10.1074\/jbc.R600038200.","journal-title":"JBC"},{"issue":"1","key":"2222_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/s0168-8278(99)80006-3","volume":"30","author":"A Fennekohl","year":"1999","unstructured":"Fennekohl A, Schieferdecker HL, Jungermann K, P\u00fcschel GP. Differential expression of prostanoid receptors in hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver. J Hepatol. 1999;30(1):38\u201347. https:\/\/doi.org\/10.1016\/s0168-8278(99)80006-3.","journal-title":"J Hepatol"},{"issue":"12","key":"2222_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958\u201369. https:\/\/doi.org\/10.1038\/nri2448.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2222_CR34","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1073\/pnas.0915000107","volume":"107","author":"EEB Ghosn","year":"2010","unstructured":"Ghosn EEB, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. PNAS. 2010;107(6):2568\u201373. https:\/\/doi.org\/10.1073\/pnas.0915000107.","journal-title":"PNAS"},{"issue":"3","key":"2222_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cell.2016.03.009","volume":"165","author":"J Wang","year":"2016","unstructured":"Wang J, Kubes P. A reservoir of mature cavity macrophages that can rapidly invade visceral organs to affect tissue repair. Cell. 2016;165(3):668\u201378. https:\/\/doi.org\/10.1016\/j.cell.2016.03.009.","journal-title":"Cell"},{"issue":"3","key":"2222_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","volume":"75","author":"X Xiong","year":"2019","unstructured":"Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, et al. Landscape of intercellular crosstalk in healthy and NASH liver revealed by Single-Cell secretome gene analysis. Mol Cell. 2019;75(3):644\u2013e6605. https:\/\/doi.org\/10.1016\/j.molcel.2019.07.028.","journal-title":"Mol Cell"},{"issue":"3","key":"2222_CR37","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/hep.30506","volume":"70","author":"J Cai","year":"2019","unstructured":"Cai J, Zhang X-J, Li H. The role of innate immune cells in nonalcoholic steatohepatitis. Hepatology. 2019;70(3):1026\u201337. https:\/\/doi.org\/10.1002\/hep.30506.","journal-title":"Hepatology"},{"issue":"2","key":"2222_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/hep.510270226","volume":"27","author":"AB Lentsch","year":"1998","unstructured":"Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia\/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology. 1998;27(2):507\u201312. https:\/\/doi.org\/10.1002\/hep.510270226.","journal-title":"Hepatology"},{"key":"2222_CR39","doi-asserted-by":"publisher","first-page":"10321","DOI":"10.1038\/ncomms10321","volume":"7","author":"CL Scott","year":"2016","unstructured":"Scott CL, Zheng F, de Baetselier P, Martens L, Saeys Y, de Prijck S, et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. 2016;7:10321. https:\/\/doi.org\/10.1038\/ncomms10321.","journal-title":"Nat Commun"},{"issue":"2","key":"2222_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2017.07.018","volume":"47","author":"F Sierro","year":"2017","unstructured":"Sierro F, Evrard M, Rizzetto S, Melino M, Mitchell AJ, Florido M, et al. A liver capsular network of Monocyte-Derived macrophages restricts hepatic dissemination of intraperitoneal Bacteria by neutrophil recruitment. Immunity. 2017;47(2):374\u2013e3886. https:\/\/doi.org\/10.1016\/j.immuni.2017.07.018.","journal-title":"Immunity"},{"issue":"2","key":"2222_CR41","doi-asserted-by":"publisher","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","volume":"34","author":"S Daemen","year":"2021","unstructured":"Daemen S, Gainullina A, Kalugotla G, He L, Chan MM, Beals JW, et al. Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH. Cell Rep. 2021;34(2):108626. https:\/\/doi.org\/10.1016\/j.celrep.2020.108626.","journal-title":"Cell Rep"},{"issue":"3","key":"2222_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","volume":"53","author":"A Remmerie","year":"2020","unstructured":"Remmerie A, Martens L, Thon\u00e9 T, Castoldi A, Seurinck R, Pavie B, et al. Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver. Immunity. 2020;53(3):641\u2013e65714. https:\/\/doi.org\/10.1016\/j.immuni.2020.08.004.","journal-title":"Immunity"},{"issue":"3","key":"2222_CR43","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","volume":"53","author":"S Tran","year":"2020","unstructured":"Tran S, Baba I, Poupel L, Dussaud S, Moreau M, G\u00e9lineau A, et al. Impaired Kupffer cell Self-Renewal alters the liver response to lipid overload during Non-alcoholic steatohepatitis. Immunity. 2020;53(3):627\u2013e6405. https:\/\/doi.org\/10.1016\/j.immuni.2020.06.003.","journal-title":"Immunity"},{"issue":"764","key":"2222_CR44","doi-asserted-by":"publisher","first-page":"eadi0284","DOI":"10.1126\/scitranslmed.adi0284","volume":"16","author":"I Jeelani","year":"2024","unstructured":"Jeelani I, Moon J-S, da Cunha FF, Nasamran CA, Jeon S, Zhang X, et al. HIF-2\u03b1 drives hepatic Kupffer cell death and Proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis. Sci Transl Med. 2024;16(764):eadi0284. https:\/\/doi.org\/10.1126\/scitranslmed.adi0284.","journal-title":"Sci Transl Med"},{"issue":"6","key":"2222_CR45","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","volume":"52","author":"JS Seidman","year":"2020","unstructured":"Seidman JS, Troutman TD, Sakai M, Gola A, Spann NJ, Bennett H, et al. Niche-Specific Re-Programming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity. 2020;52(6):1057\u2013e10747. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.001.","journal-title":"Immunity"},{"issue":"3","key":"2222_CR46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","volume":"69","author":"O Krenkel","year":"2020","unstructured":"Krenkel O, Hundertmark J, Abdallah AT, Kohlhepp M, Puengel T, Roth T, et al. Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. Gut. 2020;69(3):551\u201363. https:\/\/doi.org\/10.1136\/gutjnl-2019-318382.","journal-title":"Gut"},{"issue":"3","key":"2222_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1432-1033.1990.tb19161.x","volume":"191","author":"T Peters","year":"1990","unstructured":"Peters T, Karck U, Decker K. Interdependence of tumor necrosis factor, prostaglandin E2, and protein synthesis in lipopolysaccharide-exposed rat Kupffer cells. Eur J Biochem. 1990;191(3):583\u20139. https:\/\/doi.org\/10.1111\/j.1432-1033.1990.tb19161.x.","journal-title":"Eur J Biochem"},{"issue":"1\u20134","key":"2222_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.prostaglandins.2004.07.005","volume":"74","author":"L Treffkorn","year":"2004","unstructured":"Treffkorn L, Scheibe R, Maruyama T, Dieter P. PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages. Prostaglandins Other Lipid Mediat. 2004;74(1\u20134):113\u201323. https:\/\/doi.org\/10.1016\/j.prostaglandins.2004.07.005.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"6","key":"2222_CR49","doi-asserted-by":"publisher","first-page":"e0158316","DOI":"10.1371\/journal.pone.0158316","volume":"11","author":"SN Vallerie","year":"2016","unstructured":"Vallerie SN, Kramer F, Barnhart S, Kanter JE, Breyer RM, Andreasson KI, et al. Myeloid cell prostaglandin E2 receptor EP4 modulates cytokine production but not atherogenesis in a mouse model of type 1 diabetes. PLoS ONE. 2016;11(6):e0158316. https:\/\/doi.org\/10.1371\/journal.pone.0158316.","journal-title":"PLoS ONE"},{"issue":"4","key":"2222_CR50","first-page":"719","volume":"64","author":"Y Katakami","year":"1988","unstructured":"Katakami Y, Nakao Y, Koizumi T, Katakami N, Ogawa R, Fujita T. Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular Cyclic AMP. Immunology. 1988;64(4):719\u201324.","journal-title":"Immunology"},{"issue":"11","key":"2222_CR51","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1016\/S0021-9258(18)60727-6","volume":"263","author":"SL Kunkel","year":"1988","unstructured":"Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988;263(11):5380\u20134.","journal-title":"J Biol Chem"},{"key":"2222_CR52","doi-asserted-by":"publisher","unstructured":"Zas\u0142ona Z, P\u00e5lsson-McDermott EM, Menon D, Haneklaus M, Flis E, Prendeville H et al. Baltimore, Md. The Induction of Pro-IL-1\u03b2 by Lipopolysaccharide Requires Endogenous Prostaglandin E2 Production. J. Immun. (Baltimore, Md. 1950). 2017;198(9):3558\u20133564. https:\/\/doi.org\/10.4049\/jimmunol.1602072","DOI":"10.4049\/jimmunol.1602072"},{"key":"2222_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0165-2478(92)90015-g","volume":"31","author":"MW Fieren","year":"1991","unstructured":"Fieren MW, van den Bemd GJ, Ben-Efraim S, Bonta IL. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than Interleukin 1 beta, from human macrophages. Immunol Lett. 1991;31:85\u201390. https:\/\/doi.org\/10.1016\/0165-2478(92)90015-g.","journal-title":"Immunol Lett"},{"issue":"4","key":"2222_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/glia.10182","volume":"42","author":"P Repovic","year":"2003","unstructured":"Repovic P, Mi K, Benveniste EN. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia. 2003;42(4):433\u201346. https:\/\/doi.org\/10.1002\/glia.10182.","journal-title":"Glia"},{"issue":"7","key":"2222_CR55","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.4049\/jimmunol.166.7.4689","volume":"166","author":"R Ikegami","year":"2001","unstructured":"Ikegami R, Sugimoto Y, Segi E, Katsuyama M, Karahashi H, Amano F, et al. The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H\/HeN peritoneal macrophages. J Immun. 2001;166(7):4689\u201396. https:\/\/doi.org\/10.4049\/jimmunol.166.7.4689.","journal-title":"J Immun"},{"issue":"9","key":"2222_CR56","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/s0006-2952(01)00586-x","volume":"61","author":"S Shinomiya","year":"2001","unstructured":"Shinomiya S, Naraba H, Ueno A, Utsunomiya I, Maruyama T, Ohuchida S, et al. Regulation of TNF\u03b1 and interleukin-10 production by prostaglandins I2 and E2: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem Pharmacol. 2001;61(9):1153\u201360. https:\/\/doi.org\/10.1016\/s0006-2952(01)00586-x.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2222_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1189\/jlb.1203627","volume":"76","author":"J Akaogi","year":"2004","unstructured":"Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, Satoh M. Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J Leukoc Biol. 2004;76(1):227\u201336. https:\/\/doi.org\/10.1189\/jlb.1203627.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2222_CR58","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/BJ20111052","volume":"443","author":"MD D\u00edaz-Mu\u00f1oz","year":"2012","unstructured":"D\u00edaz-Mu\u00f1oz MD, Osma-Garc\u00eda IC, Fresno M, I\u00f1iguez MA. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem J. 2012;443(2):451\u201361. https:\/\/doi.org\/10.1042\/BJ20111052.","journal-title":"Biochem J"},{"key":"2222_CR59","doi-asserted-by":"publisher","first-page":"155241","DOI":"10.1016\/j.cyto.2020.155241","volume":"136","author":"J Klauder","year":"2020","unstructured":"Klauder J, Henkel J, Vahrenbrink M, Wohlenberg A-S, Camargo RG, P\u00fcschel GP. Direct and indirect modulation of LPS-induced cytokine production by insulin in human macrophages. Cytokine. 2020;136:155241. https:\/\/doi.org\/10.1016\/j.cyto.2020.155241.","journal-title":"Cytokine"},{"issue":"2\u20133","key":"2222_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0014-2999(97)01383-6","volume":"340","author":"Y Boie","year":"1997","unstructured":"Boie Y, Stocco R, Sawyer N, Slipetz DM, Ungrin MD, Neusch\u00e4fer-Rube F, et al. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol. 1997;340(2\u20133):227\u201341. https:\/\/doi.org\/10.1016\/s0014-2999(97)01383-6.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2222_CR61","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0026-895X(25)09407-6","volume":"50","author":"N Nishigaki","year":"1996","unstructured":"Nishigaki N, Negishi M, Ichikawa A. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist. Mol Pharmacol. 1996;50(4):1031\u20137.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"2222_CR62","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/joim.13505","volume":"292","author":"CO Stiller","year":"2022","unstructured":"Stiller CO, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials. J Intern Med. 2022;292(4):557\u201374. https:\/\/doi.org\/10.1111\/joim.13505.","journal-title":"J Intern Med"},{"issue":"2","key":"2222_CR63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.therap.2018.11.002","volume":"74","author":"N Moore","year":"2019","unstructured":"Moore N, Duong M, Gulmez SE, Blin P, Droz C. Pharmacoepidemiology of non-steroidal anti-inflammatory drugs. Therapies. 2019;74(2):271\u20137. https:\/\/doi.org\/10.1016\/j.therap.2018.11.002.","journal-title":"Therapies"},{"issue":"Suppl 1","key":"2222_CR64","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1186\/1476-5926-2-S1-S35","volume":"3","author":"P Dieter","year":"2004","unstructured":"Dieter P, Scheibe R, Bezugla Y, Matth\u00e9 E, Schuch S, Treffkorn L, et al. The regulatory role of prostaglandin E2 in liver (patho) physiology is controlled at its site of synthesis and its action on the receptors. Comp Hepatol. 2004;3(Suppl 1):S35. https:\/\/doi.org\/10.1186\/1476-5926-2-S1-S35.","journal-title":"Comp Hepatol"},{"issue":"1\u20132","key":"2222_CR65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.prostaglandins.2005.11.001","volume":"79","author":"Y Bezugla","year":"2006","unstructured":"Bezugla Y, Kolada A, Kamionka S, Bernard B, Scheibe R, Dieter P. COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages. Prostaglandins Other Lipid Mediat. 2006;79(1\u20132):93\u2013100. https:\/\/doi.org\/10.1016\/j.prostaglandins.2005.11.001.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"22","key":"2222_CR66","doi-asserted-by":"publisher","first-page":"23229","DOI":"10.1074\/jbc.M400443200","volume":"279","author":"L Boulet","year":"2004","unstructured":"Boulet L, Ouellet M, Bateman KP, Ethier D, Percival MD, Riendeau D, et al. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J Biol Chem. 2004;279(22):23229\u201337. https:\/\/doi.org\/10.1074\/jbc.M400443200.","journal-title":"J Biol Chem"},{"issue":"49","key":"2222_CR67","doi-asserted-by":"publisher","first-page":"31065","DOI":"10.1074\/jbc.272.49.31065","volume":"272","author":"T Fournier","year":"1997","unstructured":"Fournier T, Fadok V, Henson PM. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of Cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis. JBC. 1997;272(49):31065\u201372. https:\/\/doi.org\/10.1074\/jbc.272.49.31065.","journal-title":"JBC"},{"issue":"1","key":"2222_CR68","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1006\/bbrc.1996.5894","volume":"230","author":"H Matsumoto","year":"1997","unstructured":"Matsumoto H, Naraba H, Murakami M, Kudo I, Yamaki K, Ueno A, et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. BBRC. 1997;230(1):110\u20134. https:\/\/doi.org\/10.1006\/bbrc.1996.5894.","journal-title":"BBRC"},{"issue":"15","key":"2222_CR69","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1073\/pnas.1332766100","volume":"100","author":"CE Trebino","year":"2003","unstructured":"Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. PNAS. 2003;100(15):9044\u20139. https:\/\/doi.org\/10.1073\/pnas.1332766100.","journal-title":"PNAS"},{"issue":"10","key":"2222_CR70","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1182\/blood-2011-08-374207","volume":"119","author":"Z Zaslona","year":"2012","unstructured":"Zaslona Z, Serezani CH, Okunishi K, Aronoff DM, Peters-Golden M. Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2\/protein kinase A signaling. Blood. 2012;119(10):2358\u201367. https:\/\/doi.org\/10.1182\/blood-2011-08-374207.","journal-title":"Blood"},{"issue":"2","key":"2222_CR71","doi-asserted-by":"publisher","first-page":"e0118203","DOI":"10.1371\/journal.pone.0118203","volume":"10","author":"YR Na","year":"2015","unstructured":"Na YR, Yoon YN, Son D, Jung D, Gu GJ, Seok SH. Consistent Inhibition of cyclooxygenase drives macrophages towards the inflammatory phenotype. PLoS ONE. 2015;10(2):e0118203. https:\/\/doi.org\/10.1371\/journal.pone.0118203.","journal-title":"PLoS ONE"},{"issue":"7783","key":"2222_CR72","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, et al. Resolving the fibrotic niche of human liver cirrhosis at single cell level. Nature. 2019;575(7783):512\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1631-3.","journal-title":"Nature"},{"issue":"1","key":"2222_CR73","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.22950","volume":"50","author":"KR Karlmark","year":"2009","unstructured":"Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, et al. Hepatic recruitment of the inflammatory Gr1\u2009+\u2009monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology. 2009;50(1):261\u201374. https:\/\/doi.org\/10.1002\/hep.22950.","journal-title":"Hepatology"},{"issue":"2","key":"2222_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0168-8278(01)00109-X","volume":"35","author":"K Nakamura","year":"2001","unstructured":"Nakamura K, Okada M, Yoneda M, Takamoto S, Nakade Y, Tamori K, et al. Macrophage inflammatory protein-2 induced by TNF-\u03b1 plays a pivotal role in Concanavalin A-induced liver injury in mice. J Hepatol. 2001;35(2):217\u201324. https:\/\/doi.org\/10.1016\/S0168-8278(01)00109-X.","journal-title":"J Hepatol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02222-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02222-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02222-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:37:58Z","timestamp":1747377478000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02222-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02222-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}